The Relationship Between Left Atrial Pressure and Cardiac Function After Atrioventricular Node Ablation
LAP-TOP
Effects of Left Atrial Pressure-guided Ventricular Rate Regulation on Cardiac Function in Patients Therapy With Atrioventricular Node Ablation Combined With Left Bundle Branch Pacing
1 other identifier
interventional
140
1 country
1
Brief Summary
Effects of left atrial pressure-guided ventricular rate changes on cardiac function after atrioventricular node ablation combined with left bundle branch pacing
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable atrial-fibrillation
Started Jan 2021
Shorter than P25 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedFirst Submitted
Initial submission to the registry
June 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2022
CompletedFirst Posted
Study publicly available on registry
July 8, 2022
CompletedJuly 8, 2022
July 1, 2022
1.3 years
June 28, 2022
July 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EF%
aortic vestibular ejection fraction
1-year
Secondary Outcomes (2)
cardiovascular all-cause mortality
1week
Hospitalizations for heart failure
1 years
Study Arms (2)
LAP Group
EXPERIMENTALControl of left atrial pressure changes by adjusting pacemaker frequency
Control Group
NO INTERVENTIONGeneral pacemaker rate setting
Interventions
For patients after atrioventricular node ablation combined with left atrial appendage closure, the regulation of left atrial pressure can be controlled by adjusting the frequency of pacemaker.
Eligibility Criteria
You may qualify if:
- years old atrial fibrillation patients
You may not qualify if:
- There is a history of pacemaker implantation; patients after coronary artery bypass grafting; severe coronary stenosis or occlusion cannot be treated with reperfusion;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jun Zhang
Shanghai, Shanghai Municipality, 200072, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yawei Xu, Ph.D
Shanghai 10th People's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Cardiology
Study Record Dates
First Submitted
June 28, 2022
First Posted
July 8, 2022
Study Start
January 1, 2021
Primary Completion
May 1, 2022
Study Completion
June 28, 2022
Last Updated
July 8, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- After the research results are published;2 years;
- Access Criteria
- open